BPP-1001

N/A

Report date: 2023/05/22 10:20:12
NME

Base Information

Drug NameBPP-1001
Drug Alias NameBPP-1001
ClassificationSmall molecules
Mechanisms of Action5-lipoxygenase activating protein inhibitors
Targets5-lipoxygenase activating protein
Therapy Area/IndicationsBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioscience Pharma Partners LLC
China Registration ClassN/A

Develop Information

Active CompaniesBioscience Pharma Partners LLC
Inactive CompaniesN/A
Active IndicationsBrain Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A